Chlorpheniramine maleate 4 mg / phenylephrine HCl 10 mg / phenylpropanolamine HCl 50 mg / pyrilamine maleate 25 mg Oral Tablet
RxNorm 2181317
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2181317 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: chlorpheniramine maleate 4 mg / phenylephrine HCl 10 mg / phenylpropanolamine HCl 50 mg / pyrilamine maleate 25 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Chlorpheniramine maleate 4 mg / phenylephrine hydrochloride 10 mg / phenylpropanolamine hydrochloride 50 mg / pyrilamine maleate 25 mg Oral Tablet
(Atom ID: 12344692)
SY
Synonym (SY):
Chlorphenamine maleate 4 mg and mepyramine maleate 25 mg and phenylephrine hydrochloride 10 mg and phenylpropanolamine 50 mg oral tablet
(Atom ID: 10296058)
PSN
Prescribable Name (PSN):
Chlorpheniramine maleate 4 mg / phenylephrine HCl 10 mg / phenylpropanolamine HCl 50 mg / pyrilamine maleate 25 mg Oral Tablet
(Atom ID: 11433537)
PT
Designated preferred name (PT):
Chlorpheniramine maleate 4 mg and phenylephrine hydrochloride 10 mg and phenylpropanolamine 50 mg and pyrilamine maleate 25 mg oral tablet
(Atom ID: 9249506)
FN